Chennai: AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of AstraZeneca announced today that they have repositioned their Global Technology Centre (GTC) to focus on driving increased innovation, resulting in a rebrand of the centre to Global Innovation and Technology Centre (GITC).
AstraZeneca India Private Limited, the services arm of AstraZeneca, a leading science-led biopharmaceutical company, today announced the appointment of Ram Mudaliar as the India lead of their Clinical Data & Insights (CDI) division.
Ram will be responsible for establishing and expanding the CDI footprint in India, liaising with CDI global and local leaders to develop and implement strategic decisions for the India site